Tim P van de Hoef1, Froukje Nolte2, Mauro EchavarrÍa-Pinto3, Martijn A van Lavieren4, Peter Damman4, Steven A J Chamuleau5, Michiel Voskuil5, Hein J Verberne6, José P S Henriques4, Berthe L F van Eck-Smit6, Karel T Koch4, Robbert J de Winter4, Jos A E Spaan2, Maria Siebes2, Jan G P Tijssen4, Martijn Meuwissen7, Jan J Piek4. 1. AMC Heartcentre, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands Department of Biomedical Engineering and Physics, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands Hospital Clínico San Carlos and Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain. 2. Department of Biomedical Engineering and Physics, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. 3. Hospital Clínico San Carlos and Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain. 4. AMC Heartcentre, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. 5. Department of Cardiology, University Medical Centre, Utrecht, The Netherlands. 6. Department of Nuclear Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. 7. Department of Cardiology, Amphia Hospital, Breda, The Netherlands.
Abstract
BACKGROUND: Fractional flow reserve (FFR) aims to identify the extent of epicardial disease, but may be obscured by involvement of the coronary microvasculature. We documented the impact of hyperaemic stenosis resistance (HSR) and hyperaemic microvascular resistance (HMR) on FFR, and its relationship with myocardial ischaemia in patients with stable coronary artery disease. METHODS AND RESULTS: We evaluated 255 coronary arteries with stenoses of intermediate severity by means of intracoronary pressure and flow measurements to determine FFR, HSR and HMR. Myocardial perfusion scintigraphy (MPS) was performed to identify inducible myocardial ischaemia. In 178 patients, HMR was additionally determined in a reference coronary artery. Target vessel HMR was stratified according to reference vessel HMR tertiles. The diagnostic OR for inducible ischaemia on MPS of a positive compared with a negative FFR was significantly higher only in the presence of a high HMR (at the 0.75 and 0.80 FFR cut-off). Among stenoses with a positive FFR, the prevalence of ischaemia was significantly higher when HMR was high despite equivalent FFR across the HMR groups. This was paralleled by a concomitant significant increase in HSR with increasing HMR across groups. The relation between FFR and HSR (r(2)=0.54, p<0.001) was modulated by the magnitude of HMR, and improved substantially after adjustment for HMR (adjusted-r(2)=0.73, p<0.001), where, for epicardial disease of equivalent severity, FFR increased with increasing HMR. CONCLUSIONS: Identification of epicardial disease severity by FFR is partly obscured by the microvascular resistance, which illustrates the necessity of combined pressure and flow measurements in daily practice. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
BACKGROUND: Fractional flow reserve (FFR) aims to identify the extent of epicardial disease, but may be obscured by involvement of the coronary microvasculature. We documented the impact of hyperaemic stenosis resistance (HSR) and hyperaemic microvascular resistance (HMR) on FFR, and its relationship with myocardial ischaemia in patients with stable coronary artery disease. METHODS AND RESULTS: We evaluated 255 coronary arteries with stenoses of intermediate severity by means of intracoronary pressure and flow measurements to determine FFR, HSR and HMR. Myocardial perfusion scintigraphy (MPS) was performed to identify inducible myocardial ischaemia. In 178 patients, HMR was additionally determined in a reference coronary artery. Target vessel HMR was stratified according to reference vessel HMR tertiles. The diagnostic OR for inducible ischaemia on MPS of a positive compared with a negative FFR was significantly higher only in the presence of a high HMR (at the 0.75 and 0.80 FFR cut-off). Among stenoses with a positive FFR, the prevalence of ischaemia was significantly higher when HMR was high despite equivalent FFR across the HMR groups. This was paralleled by a concomitant significant increase in HSR with increasing HMR across groups. The relation between FFR and HSR (r(2)=0.54, p<0.001) was modulated by the magnitude of HMR, and improved substantially after adjustment for HMR (adjusted-r(2)=0.73, p<0.001), where, for epicardial disease of equivalent severity, FFR increased with increasing HMR. CONCLUSIONS: Identification of epicardial disease severity by FFR is partly obscured by the microvascular resistance, which illustrates the necessity of combined pressure and flow measurements in daily practice. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Tim P van de Hoef; Joo Myung Lee; Mauro Echavarria-Pinto; Bon-Kwon Koo; Hitoshi Matsuo; Manesh R Patel; Justin E Davies; Javier Escaned; Jan J Piek Journal: Nat Rev Cardiol Date: 2020-05-14 Impact factor: 32.419
Authors: Tara Shah; Joshua D Geleris; Ming Zhong; Rajesh V Swaminathan; Luke K Kim; Dmitriy N Feldman Journal: J Thorac Dis Date: 2017-04 Impact factor: 2.895
Authors: Krishna K Patel; John A Spertus; Paul S Chan; Brett W Sperry; Firas Al Badarin; Kevin F Kennedy; Randall C Thompson; James A Case; A Iain McGhie; Timothy M Bateman Journal: Eur Heart J Date: 2020-02-01 Impact factor: 29.983
Authors: John C Moscona; Jason D Stencel; Gregory Milligan; Christopher Salmon; Rohit Maini; Paul Katigbak; Qusai Saleh; Ryan Nelson; Sudesh Srivastav; Owen Mogabgab; Rohan Samson; Thierry Le Jemtel Journal: Ann Transl Med Date: 2018-08
Authors: Sascha Beck; Valeria Martínez Pereyra; Andreas Seitz; Johanna McChord; Astrid Hubert; Raffi Bekeredjian; Udo Sechtem; Peter Ong Journal: Eur Cardiol Date: 2021-07-05
Authors: Ruben W de Winter; Ruurt A Jukema; Pepijn A van Diemen; Stefan P Schumacher; Roel S Driessen; Wynand J Stuijfzand; Henk Everaars; Michiel J Bom; Albert C van Rossum; Peter M van de Ven; Niels J Verouden; Alexander Nap; Pieter G Raijmakers; Ibrahim Danad; Paul Knaapen Journal: Eur Heart J Cardiovasc Imaging Date: 2022-06-01 Impact factor: 9.130